Solventum Corporation (BST:KB7)

Market Cap	9.68B -18.2%
Revenue (ttm)	7.09B +0.9%
Net Income	1.33B +224.8%
EPS	7.56 +221.7%
Shares Out	n/a
PE Ratio	7.30
Forward PE	10.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	165
Open	55.20
Previous Close	55.80
Day's Range	55.20 - 55.20
52-Week Range	53.80 - 75.00
Beta	n/a
RSI	39.66
Earnings Date	May 7, 2026

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tap...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 20,584
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: KB7

Financial Performance

In 2025, Solventum's revenue was $8.33 billion, an increase of 0.86% compared to the previous year's $8.25 billion. Earnings were $1.56 billion, an increase of 224.84%.

Financial numbers in USD